Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$196.8M
88M shares
52-week range
$2.12 – $4.06
8% from low
Exchange
NASDAQ
CS
Borrow rate
1.06%
Moderate
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.7M | $31.3M | $83.3M | $181.1M | $356.9M | $487.7M | $522.3M | $594.0M |
| Cost of revenue | $5.6M | $20.0M | $52.5M | $117.1M | $255.9M | $356.4M | $379.8M | $440.5M |
| Gross profit | $2.9M | $11.3M | $30.8M | $64.0M | $101.0M | $131.3M | $142.5M | $153.5M |
| Gross margin | 32.8% | 36.2% | 37.0% | 35.3% | 28.3% | 26.9% | 27.3% | 25.8% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$3.7M | −$19.9M | $91.0K | −$18.7M | −$72.3M | −$41.4M | $5.0M | −$14.4M |
| EBITDA | −$5.8M | −$22.3M | $8.7M | −$2.0M | −$33.6M | −$4.2M | $33.8M | −$13.7M |
| Net income | −$4.5M | −$26.3M | −$7.0M | −$34.4M | −$71.8M | −$39.3M | −$4.3M | −$50.7M |
| Net margin | -51.7% | -84.0% | -8.4% | -19.0% | -20.1% | -8.1% | -0.8% | -8.5% |
| EPS (diluted) | -0.35 | -1.99 | -0.45 | -0.83 | -1.13 | -0.53 | -0.05 | -0.62 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $701M | $0.04 | $-0.02–$0.07 | 4 |
| 2027 | $781M | $0.19 | $0.13–$0.25 | 3 |
| 2028 | $848M | $0.26 | $0.25–$0.27 | 2 |
| 2029 | $879M | $0.45 | $0.44–$0.46 | 1 |
Forward consensus · source: Financial Modeling Prep
High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.
www.hightideinc.comNo one on the platform currently holds HITI.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 1,067,632 | $2.4M |
| Execution date | Ratio |
|---|---|
| 2021-05-13 | 1-for-15reverse |
No one on the platform has traded HITI yet.
| — |
| SENSSenseonics Holdings, Inc. | $5.94 | +3.85% | $248M | — |
| SGHTSight Sciences, Inc. | $5.84 | +2.64% | $318M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$CALC As expected to dollar land!! We did it!! Huge upside potential $HITI. Don’t miss it. Early bird tastes honey!!
View on StockTwits ↗$HITI Europe: More Than Just Germany Many investors still view Remexian as a German acquisition. I don't. Since acquiring Remexian, High Tide has: 🟢 Increased German medical cannabis market share from ~5% to ~14% 🟢 Successfully resolved major procurement challenges 🟢 Recovered gross margins to 27% 🟢 Secured exclusive supply agreements with leading Canadian LPs 🟢 Established itself as one of Germany's leading medical cannabis distributors Germany is already Europe's largest medical cannabis market. Management has repeatedly highlighted the UK as its next strategic opportunity, with independent forecasts projecting a medical cannabis market of ~£900M by 2030. France, Poland and other European markets are gradually opening as well. To me, High Tide didn't buy Germany. It bought a gateway into Europe. $HITI $MSOS $GTBIF $TRLV
View on StockTwits ↗$HITI The company either prospers or doesn't and the message board battle shrivels away, the participants usually never to be seen again. Anyway I'm in my 80's now and at some point became painfully aware that there are many more important things for me in life than proving to a group of nameless, faceless alias' that my perspective is the right one. Especially when most times I ended up realizing that I was only partially right, at best, and every time it didn't matter from a larger perspective.
View on StockTwits ↗$HITI Procurement: The Most Overlooked Competitive Advantage? Most investors compare cannabis companies by: • Revenue • EBITDA • Store count But mature industries often reward something else. 🟢 Costco didn't become successful because it produced food. 🟢 Walmart doesn't manufacture consumer goods. 🟢 McKesson doesn't invent pharmaceuticals. They control purchasing power. The larger the purchasing volume... 🟢 the better the prices 🟢 the stronger the supplier relationships 🟢 the greater the product selection 🟢 the higher the potential margin Raj Grover rarely talks about becoming the largest grower. Instead, he repeatedly talks about procurement and building the largest cannabis menu. Could procurement become one of High Tide's biggest competitive advantages? Next: Why Europe could be much bigger than most investors expect. $HITI $MSOS $GTBIF $TRLV
View on StockTwits ↗$HITI Follow The Money One of the best ways to understand a company is to ignore what management says... ...and look at where they allocate capital. Over the past few years, Raj Grover acquired: 🟢 Smoke Cartel 🟢 Daily High Club 🟢 NuLeaf Naturals 🟢 FAB CBD 🟢 DankStop 🟢 Remexian Now ask yourself: What do these companies have in common? Not cultivation. Not greenhouses. Not production. Instead, they strengthened: 🟢 Customer access 🟢 E-commerce 🟢 Distribution 🟢 Procurement 🟢 Europe One acquisition after another follows the same direction. Whether that strategy ultimately succeeds remains to be seen. But it doesn't look random. It looks intentional. Next: Why procurement may become more valuable than cultivation. $HITI $MSOS $GTBIF $TRLV
View on StockTwits ↗$HITI The High Tide Research Series part one of many Most investors still value $HITI as a Canadian cannabis retailer. I think that's becoming an outdated way to look at the company. Today's High Tide is building several businesses simultaneously: 🟢 Canada's largest cannabis retail network by store count 🟢 Europe's fastest-growing medical cannabis distributor through Remexian 🟢 One of the industry's largest cannabis loyalty ecosystems 🟢 Procurement-first business model instead of cultivation 🟢 Growing White Label strategy 🟢 Global CBD & e-commerce ecosystem The question is no longer: "How many stores does High Tide own?" The better question is: "What business is High Tide becoming?" This series isn't about hype. It's about understanding the strategy Raj Grover has been building for years. Next: Why procurement may ultimately become more valuable than cultivation. $HITI $MSOS $GTBIF $TRLV $VRNO
View on StockTwits ↗$HITI GONNA GO OUT ON A LIMB AND SAY YOU CAN GO AHEAD AND CROWN THIS ONE…
View on StockTwits ↗$MSOS $HITI $GTBIF $TRLV $CURLD Schedule I drugs are defined by the DEA as having no currently accepted medical use. Medical cannabis has now been classified as Schedule 3, which means it does have a currently accepted medical use. If cannabis has an accepted medical use, recreational cannabis no longer fits the definition of a Schedule I drug. Case closed.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 0.3× sales vs its 0.4× historical median P/S.
Fair value ≈ $2.52 · price $2.28 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.